DCF — PROWERS MEDICAL CENTER
Enterprise Value: $-17.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-17.8M
Enterprise Value
$-6.6M
PV of Cash Flows
$-11.2M
PV of Terminal Value
$-18.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $38.8M | $-0.6M | -2.0% | $-2.2M | $-2.0M |
| Year 2 | $40.0M | $-0.2M | -1.0% | $-1.9M | $-1.6M |
| Year 3 | $41.2M | $0.2M | 0.0% | $-1.6M | $-1.2M |
| Year 4 | $42.4M | $0.4M | 1.0% | $-1.4M | $-1.0M |
| Year 5 | $43.7M | $0.5M | 1.0% | $-1.3M | $-0.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-17.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$37.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.020498038802697318
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5